ATE269313T1 - Tryptase-inhibitoren - Google Patents

Tryptase-inhibitoren

Info

Publication number
ATE269313T1
ATE269313T1 AT00985174T AT00985174T ATE269313T1 AT E269313 T1 ATE269313 T1 AT E269313T1 AT 00985174 T AT00985174 T AT 00985174T AT 00985174 T AT00985174 T AT 00985174T AT E269313 T1 ATE269313 T1 AT E269313T1
Authority
AT
Austria
Prior art keywords
tryptase inhibitors
inhibitors
tryptase
compounds
formula
Prior art date
Application number
AT00985174T
Other languages
English (en)
Inventor
Thomas Baer
Josef Stadlwieser
Wolf-Ruediger Ulrich
Andreas Dominik
Daniela Bundschuh
Karl Zech
Christian Sommerhoff
Thomas Martin
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE269313T1 publication Critical patent/ATE269313T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00985174T 1999-12-20 2000-12-16 Tryptase-inhibitoren ATE269313T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99125384 1999-12-20
PCT/EP2000/012838 WO2001046168A1 (en) 1999-12-20 2000-12-16 Tryptase inhibitors

Publications (1)

Publication Number Publication Date
ATE269313T1 true ATE269313T1 (de) 2004-07-15

Family

ID=8239661

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00985174T ATE269313T1 (de) 1999-12-20 2000-12-16 Tryptase-inhibitoren

Country Status (13)

Country Link
US (1) US7015325B2 (de)
EP (1) EP1244643B1 (de)
JP (1) JP2003518109A (de)
AT (1) ATE269313T1 (de)
AU (1) AU783217B2 (de)
CA (1) CA2392121A1 (de)
DE (1) DE60011677T2 (de)
DK (1) DK1244643T3 (de)
ES (1) ES2222259T3 (de)
PT (1) PT1244643E (de)
SI (1) SI1244643T1 (de)
TR (1) TR200402322T4 (de)
WO (1) WO2001046168A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1358182B1 (de) 2001-01-31 2004-08-11 ALTANA Pharma AG Diazocinderivate und deren verwendung als tryptase inhibitoren
JP2004518735A (ja) 2001-02-21 2004-06-24 アルタナ　ファルマ　アクチエンゲゼルシャフト トリプターゼインヒビター
WO2002066430A1 (en) 2001-02-21 2002-08-29 Altana Pharma Ag Tryptase inhibitors
EP1370518A2 (de) * 2001-03-15 2003-12-17 ALTANA Pharma AG Tryptase hemmer
WO2002074732A2 (en) * 2001-03-15 2002-09-26 Altana Pharma Ag Tryptase-inhibitors
US6962941B2 (en) 2001-06-19 2005-11-08 Altana Pharma Ag Tryptase inhibitors
GB0507577D0 (en) * 2005-04-14 2005-05-18 Novartis Ag Organic compounds
WO2018183654A1 (en) 2017-03-29 2018-10-04 Minerva Biotechnologies Corporation Agents for differentiating stem cells and treating cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3999946A (en) * 1976-02-23 1976-12-28 Allied Chemical Corporation Time-temperature history indicators
US4228126A (en) * 1977-11-25 1980-10-14 Allied Chemical Corporation Diacetylene time-temperature indicators
US5656660A (en) * 1994-06-01 1997-08-12 Arris Pharmaceutical Corporation Compositions and methods for treating mast-cell mediated conditions
SK37997A3 (en) * 1994-09-23 1998-12-02 Arris Pharm Corp Compositions and methods for treating mast-cell inflammatory condition
EP0934293A1 (de) * 1996-07-30 1999-08-11 Arris Pharmaceutical Corporation Verbindungen und präparate für eine behandelung von krankheiten die mit tryptaseaktivität zusammenhangen
US6221914B1 (en) * 1997-11-10 2001-04-24 Array Biopharma Inc. Sulfonamide bridging compounds that inhibit tryptase activity
ES2233025T3 (es) 1998-02-06 2005-06-01 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Agente inhibidores de la triptasa.
US6613769B1 (en) 1998-02-06 2003-09-02 Max-Planck-Gesellschaft zur Föderung der Wissenschaften. e.V. Tryptase inhibitors
JP2003524598A (ja) 1998-09-04 2003-08-19 アルタナ ファルマ アクチエンゲゼルシャフト 新規ピラノセン
EP1208089B1 (de) 1999-08-10 2004-10-13 ALTANA Pharma AG Diazocindionderivate und ihre verwendung als tryptase inhibitoren
US6960588B1 (en) 1999-09-14 2005-11-01 Altana Pharma Ag Tryptase inhibitors

Also Published As

Publication number Publication date
EP1244643B1 (de) 2004-06-16
EP1244643A1 (de) 2002-10-02
AU783217B2 (en) 2005-10-06
CA2392121A1 (en) 2001-06-28
JP2003518109A (ja) 2003-06-03
SI1244643T1 (en) 2004-12-31
US7015325B2 (en) 2006-03-21
ES2222259T3 (es) 2005-02-01
WO2001046168A1 (en) 2001-06-28
DK1244643T3 (da) 2004-10-18
AU2166901A (en) 2001-07-03
PT1244643E (pt) 2004-10-29
DE60011677T2 (de) 2005-07-14
DE60011677D1 (en) 2004-07-22
TR200402322T4 (tr) 2004-12-21
US20030083344A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
ES2186874T3 (es) Analogos de m-amidinofenilo como inhibidores del factor xa.
PL372926A1 (en) Piperidine-pyridazones and phthalazones as pde4 inhibitors
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
BR0007922A (pt) Compostos calcilìticos
ATE269313T1 (de) Tryptase-inhibitoren
DE60202669D1 (de) 6-phenylbenzonaphthyidine
DK1204659T3 (da) Serotonerge benzofuraner
DK1244614T3 (da) Tryptase-inhibitorer
DE60216920D1 (en) Tryptase-inhibitoren
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
ATE364037T1 (de) Tryptasehemmer
ATE491709T1 (de) Pyrrolidinohydrochinazoline
DE60120398D1 (de) Imidazopyridin-8-one
DK1358182T3 (da) Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer
ATE349427T1 (de) Tryptaseinhibitoren
AU758194C (en) Novel benzimidazoles and benzoxazoles
SG145571A1 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1244643

Country of ref document: EP

REN Ceased due to non-payment of the annual fee